Research Directory

Breakthroughs for European bipharma over the horizon

Read more

Treating hearing loss as people age

Read more

European Biopharma R&D in 2023

Read more

How a lung delivery issue unlocked RNA

Read more

New opportunities awaited travellers to San Francisco

Read more

EMA reflects on 2023

Read more

A regulatory win for a rare disease strategy

Read more

How private European MidPharmas sustain innovation

Read more

Oncology Review: New drugs for myeloma, breast cancer reached the market in 2023

Read more

EMA adopts AI workplan

Read more